Keywords
Serology
Prenatal screening
Submitted : 2024-05-26
Accepted : 2024-06-10
Published : 2024-06-25
Abstract
Objective: To analyze the results of maternal serological prenatal screening in the middle trimester. Methods: The study was conducted on 7815 middle-pregnant women who underwent prenatal screening in our hospital between January 2021 and December 2022, of which pregnant women aged 35 years and above were taken as the high-age group; those who were under 35 years old were included in the low-age group. The results of maternal serological screening in mid-pregnancy were analyzed. Results: The probability of detecting the disease was higher in prenatal screening results. Conclusion: Maternal serologic prenatal screening in the middle trimester has the advantages of economy and convenience, and can effectively reduce birth defects in newborns, which is of some value for promotion.
References
Deng Z, Zhu X, Bai T, et al., 2022, Preparation and Evaluation of Quality Management Samples for Noninvasive DNA Prenatal Screening. Chinese Journal of Medical Genetics, 39(2):176-180.
Chinese Association of Eugenics Science Medical Genetics Committee, Li J, She M, et al., 2022, Expert Consensus on Scientific Management of Serologic Prenatal Screening. Chinese Journal of Medical Genetics, 39(5): 464–467.
Wang R, Yang LH, Liu W, et al., 2023, Evaluation of the Efficacy of Extended Noninvasive Prenatal Screening Technology in Pregnant Women of Advanced Maternal Age. International Journal of Genetics, 46(3): 191–198.
Duan H, Wang W, Zhang Y, et al., 2022, Clinical Application of Noninvasive Prenatal Screening Based on Fetal Free DNA from Maternal Peripheral Blood. Chinese Journal of Medical Genetics, 39(3): 264–268.
Wang Y, Li S, Wang W, et al., 2021, Analysis of the Efficacy of Noninvasive Prenatal Screening Technology in the Technical System of Prenatal Screening and Diagnosis. Chinese Journal of Medical Genetics, 38(4): 309–312.
Wang Yan, Chen X, Lin M, et al., 2021, Evaluation of the Efficacy of Noninvasive Prenatal Screening Technology for Fetal Sex Chromosome Variants. Chinese Journal of Medical Genetics, 38(4): 325–328.
Liu Y, Wu L, 2021, Application of High-Throughput Sequencing Technology in Prenatal Screening and Prenatal Diagnosis. Chinese Journal of Preventive Medicine, 55(9): 737–742.
Li Z, Duan H, Liu W, et al., 2024, Prenatal Diagnosis and Pregnancy Outcome Analysis of High-Risk Individuals with Peripheral Blood Fetal Free DNA Prenatal Screening. Chinese Journal of Medical Genetics, 41(1): 1–7.
Zhou Y, Zhai X, Lu Q, et al., 2023, Clinical Application of Noninvasive Prenatal Screening Technology in Fetal Sex Chromosome Aneuploidy. China Family Planning and Obstetrics and Gynecology, 15(2): 96–98 + 77.
Xing L, Liu H, 2023, Exploration of Factors Affecting Fetal Free DNA Concentration and Related Prenatal Screening/Diagnosis Strategies. Chinese Journal of Prenatal Diagnosis (Electronic Edition), 15(3): 11–19.
Xu M, 2023, Analysis of the role of Prenatal Screening and Diagnosis in Reducing the Birth Rate of Defective Children. Practical Gynecological Endocrinology Electronic Journal, 7(20): 23–25.
Liu Y, Bai G, Jia H, et al., 2023, Establishment of Median Prenatal Screening Markers by Dried Blood Spot Method in Mid-Pregnancy in Xi’an and Study on the Application Effect. China Family Planning and Obstetrics and Gynecology, 15(6): 37–41.
Qiu S, Li T, Jiang X, et al., 2023, Analysis of Infectious Indicators in 15,691 Pregnant Women Screened for Infectious Diseases for the First Time at Prenatal Screening from 2017 to 2021. Infectious Disease Information, 36(1): 65–68.
Zheng Y, Li J, Zhang J, et al. 2023, Prenatal Screening and Clinical Significance of Hereditary Deafness Gene in 64757 Pregnant Women in Xi’an. Laboratory Medicine and Clinics, 20(2): 155–159.